The FDA has accepted Belite Bio’s application for tinlarebant and [...]

Claris Biotherapeutics has raised $118 million in a Series B [...]

Aravind Eye Care System and Alcon have launched a new [...]

Atsena Therapeutics has received EMA orphan designation for two gene [...]

Tenpoint Therapeutics has submitted a Marketing Authorization Application (MAA) to [...]

Healome Therapeutics has raised £2 million in seed funding to [...]

Crowdhelix has launched a new international innovation network focused on [...]

Complement Therapeutics doses first patient in Phase 1/Phase 2 Opti-GAIN [...]

Circio Holding ASA, a biotechnology company developing circular RNA-based gene [...]

PulseSight Therapeutics has completed dosing in its Phase 1 clinical [...]